The Portfolio returned 7.33% gross, significantly outperforming the MSCI World Health Care Index's 3.12% return. Click here ...

Non-profit arm of the de-extinction company secures an additional $50 million, expands global projects and partnerships, and releases its inaugural Impact Report detailing progress in the fight ...

If the government wants to expand U.S. manufacturing, it must invest in the already booming vaccine industry. The push to ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.8% in the afternoon session after the stock's ...

RNA is usually portrayed as a molecule that works deep inside the cell, helping to turn genetic information into proteins.

European Union leaders have agreed to lend Ukraine €90 billion over the next two years, providing a critical financial ...

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...

Moderna MRNA announced that the Coalition for Epidemic Preparedness Innovations (“CEPI”) will invest up to $54.3 million in ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

The World Health Organization (WHO) welcomes a new €8 million, four-year contribution from the Government of Belgium to ...

CAMBRIDGE, MA / ACCESS Newswire / December 17, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced it will present at the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12th at 7:30 p ...